BR112013031325A2 - cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori - Google Patents

cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori

Info

Publication number
BR112013031325A2
BR112013031325A2 BR112013031325A BR112013031325A BR112013031325A2 BR 112013031325 A2 BR112013031325 A2 BR 112013031325A2 BR 112013031325 A BR112013031325 A BR 112013031325A BR 112013031325 A BR112013031325 A BR 112013031325A BR 112013031325 A2 BR112013031325 A2 BR 112013031325A2
Authority
BR
Brazil
Prior art keywords
spray
cells
helicobacter pylori
use against
lactobacillus strains
Prior art date
Application number
BR112013031325A
Other languages
English (en)
Portuguese (pt)
Inventor
Holz Caterina
Lang Christine
Goelling Detlef
Arya Stefanie
Original Assignee
Organobalance Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11169137A external-priority patent/EP2532354A1/de
Application filed by Organobalance Gmbh filed Critical Organobalance Gmbh
Publication of BR112013031325A2 publication Critical patent/BR112013031325A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112013031325A 2011-06-08 2012-06-08 cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori BR112013031325A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11169137A EP2532354A1 (de) 2011-06-08 2011-06-08 Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori
EP11185851 2011-10-19
PCT/EP2012/060948 WO2012168468A1 (de) 2011-06-08 2012-06-08 Sprühgetrocknete lactobacillus stämme / zellen und deren verwendung gegen helicobacter pylori

Publications (1)

Publication Number Publication Date
BR112013031325A2 true BR112013031325A2 (pt) 2017-06-06

Family

ID=46489179

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031325A BR112013031325A2 (pt) 2011-06-08 2012-06-08 cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori

Country Status (10)

Country Link
US (1) US20140147427A1 (https=)
EP (1) EP2717890B1 (https=)
JP (1) JP6062931B2 (https=)
CN (1) CN103648511B (https=)
BR (1) BR112013031325A2 (https=)
EA (1) EA028340B1 (https=)
ES (1) ES2600963T3 (https=)
MX (1) MX354047B (https=)
PL (1) PL2717890T3 (https=)
WO (1) WO2012168468A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150374764A1 (en) * 2013-02-07 2015-12-31 Organobalance Gmbh Composition comprising lactobacillus and a carrier
DE102014103832A1 (de) 2014-02-13 2015-08-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
WO2016085932A1 (en) * 2014-11-24 2016-06-02 Nutrition Physiology Company, Llc Lactic acid bacterium as pet dietary supplement
JP2016150904A (ja) * 2015-02-16 2016-08-22 サントリーホールディングス株式会社 抗腫瘍剤
JP6339526B2 (ja) * 2015-05-22 2018-06-06 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
CN105132329B (zh) * 2015-09-14 2019-04-16 西南民族大学 一种可预防胃溃疡的发酵乳杆菌Lactobacillus fermentum strain Lee及其保健用途
GB2544481B (en) * 2015-11-16 2019-12-11 Century International Enterprises Ltd A wearable article and a method for producing a wearable article
WO2017221799A1 (ja) * 2016-06-20 2017-12-28 株式会社明治 上部消化管内菌叢改善剤
KR101873899B1 (ko) * 2016-08-09 2018-07-03 씨제이제일제당(주) 락토바실러스 살리바리우스 cjls1511, 상기 균 또는 이의 사균체를 포함하는 동물 사료 첨가제 조성물, 및 상기 사균체의 제조 방법
AU2018251616B2 (en) * 2017-04-11 2025-04-03 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
CN107361232A (zh) * 2017-06-21 2017-11-21 安徽和盛伟业饲料有限公司 一种防治仔鸡冬季腹泻的饲料
CN108403725B (zh) * 2018-05-22 2021-02-09 浙江海正药业股份有限公司 用于治疗消化道溃疡的组合物及其应用
US11617772B2 (en) * 2018-09-11 2023-04-04 Direct Digital Llc Nutritional supplements and therapeutic compositions comprising probiotics
EP3870197A1 (en) * 2018-10-24 2021-09-01 Novozymes A/S Probiotic supplement for metabolic health comprising lactobacillus
WO2021099655A1 (es) * 2019-11-19 2021-05-27 Inbiolev, S.L. Procedimiento para el tratamiento de mostos y vinos y producto para la puesta en práctica del mismo
CN111357841A (zh) * 2020-03-26 2020-07-03 湖南营养树生物科技有限公司 一种抗幽门螺旋杆菌的益生菌白茶的制备方法
CN111548970B (zh) * 2020-05-29 2021-03-26 江南大学 一株能够预防和/或治疗幽门螺杆菌感染的卷曲乳杆菌
CN111471626A (zh) * 2020-05-29 2020-07-31 江南大学 一株能够抑制幽门螺杆菌的瑞士乳杆菌及其应用
CN111632084B (zh) * 2020-06-22 2024-04-26 上海利康精准医疗技术有限公司 一种抑制幽门螺旋杆菌的复合益生菌组合物及其应用
CN112314951A (zh) * 2020-12-04 2021-02-05 王立强 一种可抗幽门螺杆菌的组合物及其制备方法
CN114561313B (zh) * 2021-08-26 2022-09-13 佛山市孛特碧欧微生物科技有限公司 格氏乳杆菌及其应用
CN116004456B (zh) * 2022-12-27 2023-10-27 广西爱生生命科技有限公司 一株抑制幽门螺旋杆菌感染的罗伊氏乳杆菌a21325及其应用
WO2024252018A1 (en) * 2023-06-08 2024-12-12 Dsm Ip Assets B.V. Novel process for producing lactobacillus rhamnosus
GB2634493A (en) * 2023-09-05 2025-04-16 Lant Medical Ltd Veterinary non-antibiotic antimicrobial compositions
WO2025132761A1 (en) 2023-12-22 2025-06-26 Novozymes A/S Producing a lactobacillus strain

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897307A (en) * 1974-10-23 1975-07-29 Hansens Lab Inc Stabilized dry cultures of lactic acid-producing bacteria
DE3135329A1 (de) 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
EP0285682B2 (en) 1987-04-06 1997-08-06 F. Hoffmann-La Roche Ag Process for the manufacture of vitamin preparations
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP4509250B2 (ja) * 1999-06-24 2010-07-21 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
FR2801316B1 (fr) * 1999-11-18 2005-03-25 Rhodia Food Procede de sechage des bacteries
JP3363438B2 (ja) * 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE60238663D1 (de) * 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
WO2004087891A1 (en) * 2003-04-02 2004-10-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
DK3067057T3 (da) * 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
WO2008060198A1 (en) * 2006-11-17 2008-05-22 Sca Hygiene Products Ab Lactobacillus fermentum ess-1, dsm17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
EA020627B1 (ru) * 2008-06-26 2014-12-30 Синва Фармасьютикал Ко., Лтд. Способ получения клеток наноразмерных молочно-кислых бактерий и композиции на их основе

Also Published As

Publication number Publication date
CN103648511B (zh) 2018-12-07
MX354047B (es) 2018-02-09
EA028340B1 (ru) 2017-11-30
JP6062931B2 (ja) 2017-01-18
ES2600963T3 (es) 2017-02-13
EP2717890A1 (de) 2014-04-16
EA201391823A1 (ru) 2014-04-30
WO2012168468A1 (de) 2012-12-13
PL2717890T3 (pl) 2017-12-29
JP2014518897A (ja) 2014-08-07
MX2013014340A (es) 2014-07-09
CN103648511A (zh) 2014-03-19
US20140147427A1 (en) 2014-05-29
EP2717890B1 (de) 2016-08-10

Similar Documents

Publication Publication Date Title
BR112013031325A2 (pt) cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori
BR112013016905A2 (pt) métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano
MY181854A (en) Combination, composition, and method of administering the combination or composition to animals
WO2012149549A3 (en) Bacillus bacteria for use in treating and preventing infection in aquatic animals
CL2011002852A1 (es) Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias.
BR112017010475A2 (pt) cepas de lactobacillus ou bifidobacterium para manter homeostase
BR112018068593A2 (pt) composições tópicas não aquosas que compreendem uma salicilanilida halogenada
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
UY32570A (es) Vacuna viva modificada de mycoplasma bovis mejorada
NZ706636A (en) Probiotic and prebiotic compositions
PH12017500708A1 (en) Probiotic and prebiotic compositions
BR112013018642A2 (pt) vacinas e composições contra streptococcus pneumoniae
BR112015022833A2 (pt) bactéria de ácido láctico ou um fragmento da mesma, bactéria de ácido láctico isolada ou um fragmento da mesma, uso de bactérias de ácido láctico ou um fragmento das mesmas, composição alimentícia, método para conservação de gêneros alimentícios, e, método de identificação de uma bactéria de ácido láctico
BR112013011088A2 (pt) composições de cereal em pó compreendendo microorganismos probióticos não replicantes
BR112015028164A2 (pt) probióticos e métodos de uso
WO2016057413A3 (en) Inhibitors of lysine gingipain
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
BR112014014973A8 (pt) preparações contendo emodepside amorfo
BR112014009580A2 (pt) composição farmacêutica de omeprazol
PH12019501439B1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
BR112012030485A2 (pt) composição para prevenção ou tratamento de osteoporose e processo de fabricação para a mesma
BR112014029515A2 (pt) vacina de vírus schmallenberg (sbv), métodos de produção e usos da mesma, virus schmallenberg, usos de seus antígenos e composição de matéria
BR112015010223A2 (pt) compostos tricíclicos para o uso no tratamento e/ou controle de obesidade
BR112014024033A8 (pt) Formulação vesicular, método para o tratamento da rosácea e uso de um ou mais fosfo, sulfolipídios e surfactantes
WO2016063265A3 (pt) Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: NOVOZYMES A/S (DK)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]